|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,687.80 INR | +0.02% |
|
+0.51% | -10.53% |
| 06-13 | India's Sun Pharma names Kirti Ganorkar as managing director | RE |
| 06-13 | India's Sun Pharma names Kirti Ganorkar as managing director | RE |
| Capitalization | 4,050B 47.03B 40.69B 38.18B 34.6B 63.88B 72.25B 446B 174B 1,854B 177B 173B 6,772B | P/E ratio 2025 |
38x | P/E ratio 2026 * | 32.8x |
|---|---|---|---|---|---|
| Enterprise value | 3,832B 44.51B 38.5B 36.13B 32.74B 60.44B 68.37B 422B 164B 1,754B 167B 163B 6,408B | EV / Sales 2025 |
7.48x | EV / Sales 2026 * | 6.56x |
| Free-Float |
44.9% | Yield 2025 |
0.92% | Yield 2026 * | 0.92% |
More valuation ratios
* Estimated data
More news
Last Transcript: Sun Pharmaceutical Industries Ltd.
More recommendations
More press releases
More news
| 1 day | +0.02% | ||
| 1 week | +0.51% | ||
| Current month | +0.61% | ||
| 1 month | -0.72% | ||
| 3 months | +0.26% | ||
| 6 months | -6.93% | ||
| Current year | -10.53% |
| 1 week | 1,661.1 |  | 1,727.5 |
| 1 month | 1,636.6 | | 1,765 |
| Current year | 1,553.05 | | 1,896 |
| 1 year | 1,460.9 | | 1,960.35 |
| 3 years | 789.9 | | 1,960.35 |
| 5 years | 452.25 | | 1,960.35 |
| 10 years | 312 | | 1,960.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Aalok Shanghvi
CEO | Chief Executive Officer | - | - |
| Chief Executive Officer | 69 | 31/12/1982 | |
| Director of Finance/CFO | - | 18/06/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | - | |
| Director/Board Member | 68 | 31/12/1993 | |
| Director/Board Member | 72 | 24/05/2018 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.02% | +0.51% | +11.72% | +103.47% | 47.03B | ||
| -1.89% | +6.98% | +13.88% | +62.69% | 26.59B | ||
| -0.95% | -2.86% | +32.88% | - | 22.69B | ||
| +0.16% | +0.07% | -2.55% | +57.65% | 14.12B | ||
| -0.39% | +1.54% | -10.60% | +177.17% | 11.39B | ||
| +1.44% | +16.88% | +89.94% | +111.34% | 8.53B | ||
| -.--% | +0.14% | - | - | 6.79B | ||
| 0.00% | +0.53% | +36.73% | +103.02% | 6.65B | ||
| -.--% | -1.95% | - | - | 5.73B | ||
| +1.85% | +5.01% | +36.34% | +344.83% | 5.47B | ||
| Average | +0.02% | +1.84% | +26.04% | +137.17% | 15.5B | |
| Weighted average by Cap. | -0.33% | +1.65% | +19.09% | +107.59% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 527B 6.12B 5.3B 4.97B 4.5B 8.32B 9.41B 58.1B 22.6B 241B 22.98B 22.49B 882B | 572B 6.65B 5.75B 5.39B 4.89B 9.02B 10.21B 63.05B 24.53B 262B 24.94B 24.4B 957B |
| Net income | 117B 1.36B 1.18B 1.1B 1B 1.85B 2.09B 12.89B 5.02B 53.56B 5.1B 4.99B 196B | 124B 1.44B 1.24B 1.17B 1.06B 1.95B 2.2B 13.62B 5.3B 56.57B 5.39B 5.27B 207B |
| Net Debt | -218B -2.53B -2.19B -2.05B -1.86B -3.43B -3.88B -23.98B -9.33B -99.61B -9.49B -9.28B -364B | -297B -3.44B -2.98B -2.8B -2.53B -4.68B -5.29B -32.68B -12.72B -136B -12.93B -12.65B -496B |
More financial data
* Estimated data
Employees
43,000
Sector
Pharmaceuticals
Calendar
07-06
- Final dividend
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/06/25 | 1,687.80 ₹ | +0.02% | 2,404,272 |
| 12/06/25 | 1,687.40 ₹ | -0.19% | 3,588,365 |
| 11/06/25 | 1,690.60 ₹ | +0.11% | 1,999,978 |
| 10/06/25 | 1,688.80 ₹ | -0.33% | 2,369,135 |
| 09/06/25 | 1,694.40 ₹ | +0.91% | 2,589,656 |
Delayed Quote NSE India S.E., June 13, 2025 at 12:49 pm
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
36
Last Close Price
1,687.80INR
Average target price
1,981.44INR
Spread / Average Target
+17.40%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SUNPHARMA Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition